Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07812948 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Personalising ADHD Medication Treatment for Children and Young People

Name: Personalising ADHD Medication Treatment for Children and Young People — clinical trial record (NCT07812948)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PETRA

StatusNot Yet Recruiting

PhaseNot applicable

SponsorUniversity of Southampton

Started2026-09

View on ClinicalTrials.gov ↗

Attention deficit hyperactivity disorder (ADHD) is a common condition that affects children's behaviour, attention and activity levels. Medicines can be an effective treatment for ADHD, but it is often difficult to know which medicine will work best for a particular child. As a result, some children may need to try several medicines before finding one that is effective and well tolerated. This study aims to test a new online decision-support system called PETRA. The system is designed to help children, parents or carers, and doctors make shared decisions about ADHD medication. The study will assess whether it is practical and acceptable to run a larger clinical trial comparing this personalised approach with standard care.

Trial Details

NCT Number	NCT07812948
Lead Sponsor	University of Southampton
Conditions	ADHD
Enrollment	102 participants
Start Date	2026-09
Primary Completion	2027-11 (estimated)
Study Completion	2028-11 (estimated)
Updated on ClinicalTrials.gov	2026-09-10